🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
This is a longitudinal, multiple-center, observational study of patients ge...
Status
Unknown
Location
Department of Neurology, Peking Union Medical College Hospital
Start Date
2022-01-01
Trial ID
NCT05187260
Treatments Being Tested
This is a multicenter, open-label Phase I/II clinical study to evaluate the...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-07-22
Trial ID
NCT07083323
Treatments Being Tested
This is a First in Human (FIH), double-blinded, parallel-group, randomised,...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2019-07-03
Trial ID
NCT04036227
This is an open-label, multicenter, Phase Ib study to determine the maximum...
Status
Completed
Location
Rigshospitalet
Start Date
2021-07-14
Trial ID
NCT04826003
Treatments Being Tested
Hypertension is a major risk factor for cardiovascular morbidity and mortal...
Status
Terminated
Location
Marine Parade Polyclinic
Start Date
2017-12-20
Trial ID
NCT03368417
Treatments Being Tested
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE
Start Date
2020-07-17
Trial ID
NCT04561362
Treatments Being Tested